跳至主要内容
临床试验/NCT04761055
NCT04761055已完成不适用

Detection of Breast Lesions Utilizing iBreast Exam: A Comparison With Clinical Breast Exam

Memorial Sloan Kettering Cancer Center2 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2021年1月29日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
300
试验地点
2
主要终点
Compare the Outcomes of the iBE Examinations to Clinical Breast Examinations (CBE)by Estimating the Sensitivity of the Device Using Imaging Results

研究概览

简要总结

This study will test the iBreastExam device to find out whether it can detect a mass or lump in the breast as accurately as a routine breast cancer screening examination.

The iBreastExam is a handheld device that performs a painless electronic palpation (examination by touch) of the breast. The device is designed to detect breast abnormalities that may require breast imaging and additional clinical examination by a nurse or doctor. The iBreastExam device creates a color map of the breast, with red spots indicating areas that may be abnormal.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female patient
  • Over 18 years of age, able to consent
  • RLC patients presenting to RLC or BAIC for mammogram and CBE
  • Asymptomatic and symptomatic patients will be included

排除标准

  • Male patients
  • Patients under 18 years of age, unable to consent
  • Pregnant patients
  • Lactating patients
  • Non-intact skin

研究组 & 干预措施

Screening Visits for Breast Cancer

Experimental

Consenting patients will receive their already scheduled standard CBE and mammogram and in addition will receive a breast exam utilizing the iBreast Exam (iBE).

干预措施: Clinical Breast exam (CBE) (Other)

Screening Visits for Breast Cancer

Experimental

Consenting patients will receive their already scheduled standard CBE and mammogram and in addition will receive a breast exam utilizing the iBreast Exam (iBE).

干预措施: iBreastExam device (Device)

Screening Visits for Breast Cancer

Experimental

Consenting patients will receive their already scheduled standard CBE and mammogram and in addition will receive a breast exam utilizing the iBreast Exam (iBE).

干预措施: mammogram (Diagnostic Test)

结局指标

主要结局

Compare the Outcomes of the iBE Examinations to Clinical Breast Examinations (CBE)by Estimating the Sensitivity of the Device Using Imaging Results

时间窗: approximately one month after imaging scan

comparing the calculated the sensitivities or the percentage of true positive breast lesions (based on imaging results) of the iBE and CBE

Compare the Outcomes of the iBE Examinations to Clinical Breast Examinations by Estimating the Specificity of the Device Using Imaging Results

时间窗: approximately one month after imaging scan

comparing the calculated the specificities or the percentage of true negative lesions (based on imaging results) of the iBE and CBE

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Study of iBreast, a Handheld Device to Detect Breast... | 临床试验